Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Marker Therapeutics (MRKR) Assets Average (2016 - 2025)

Marker Therapeutics (MRKR) has disclosed Assets Average for 11 consecutive years, with $20.4 million as the latest value for Q4 2025.

  • Quarterly Assets Average rose 23.9% to $20.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.4 million through Dec 2025, up 23.9% year-over-year, with the annual reading at $20.5 million for FY2025, 4.96% up from the prior year.
  • Assets Average for Q4 2025 was $20.4 million at Marker Therapeutics, up from $18.3 million in the prior quarter.
  • The five-year high for Assets Average was $84.4 million in Q2 2021, with the low at $11.3 million in Q3 2024.
  • Average Assets Average over 5 years is $36.1 million, with a median of $22.8 million recorded in 2023.
  • The sharpest move saw Assets Average skyrocketed 84.7% in 2021, then plummeted 55.65% in 2023.
  • Over 5 years, Assets Average stood at $70.0 million in 2021, then crashed by 46.07% to $37.8 million in 2022, then crashed by 51.53% to $18.3 million in 2023, then fell by 10.05% to $16.5 million in 2024, then rose by 23.9% to $20.4 million in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $20.4 million, $18.3 million, and $15.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.